AI Tool Offers Early Warning System for Drug Shortages

Published Date: 10 Jul 2026

A new platform developed by researchers at the University of Toronto uses real-world data and AI-enabled forecasting to identify medications that may soon be in short supply.

Read Full News

Latest News

Liberalized Diet Fails to Match Neutropenic Safety

Dr Maurie Markman discusses why modifying cancer diets without RCT data poses major risks, highlighting a trial halted due to a 10% spike in serious infections.

Chordoma Guidance Moves Into Age of Shared Decision-Making

A consensus update for chordoma 11 years in the making focuses on a multidisciplinary approach, use of biomarkers and lays out site-specific protocols.

FDA Expands Pembrolizumab-Enfortumab Vedotin Regimen in MIBC

Pembrolizumab plus enfortumab vedotin is now approved for all adults with muscle-invasive bladder cancer undergoing cystectomy.

Amplify, Apply, Advance: Bridging Academic Expertise and Community Practice to Elevate CML Care

Amplify, Apply, Advance: Bridging Academic Expertise and Community Practice to Elevate CML Care

Brain Changes Linked With Speech-in-Noise Impairment

Aspects of the "cocktail party effect" may emerge before cognitive decline is detected

No Survival Dip After Skipping Axillary Surgery for Some Early Breast Cancers

Applies to most patients with one or two positive sentinel lymph nodes

Todays Updates

Palliative Care Remains Uncommon in Young Adults With Cancer

Concurrent palliative care use among young adults with advanced cancer is less than 20%, with substantial variation across cancer types.

Todays Updates

Palliative Care Remains Uncommon in Young Adults With Cancer

Concurrent palliative care use among young adults with advanced cancer is less than 20%, with substantial variation across cancer types.

Latest News

Dr Maurie Markman discusses why modifying cancer diets without RCT data poses major risks, highlighting a trial halted due to a 10% spike in serious infections.

A consensus update for chordoma 11 years in the making focuses on a multidisciplinary approach, use of biomarkers and lays out site-specific protocols.

Pembrolizumab plus enfortumab vedotin is now approved for all adults with muscle-invasive bladder cancer undergoing cystectomy.

Amplify, Apply, Advance: Bridging Academic Expertise and Community Practice to Elevate CML Care

Aspects of the "cocktail party effect" may emerge before cognitive decline is detected

Applies to most patients with one or two positive sentinel lymph nodes

News All Time

Water Ablation Shows Early Promise for Prostate Cancer

Early findings show efficacy of water vapor therapy for treating intermediate-risk prostate cancer with minimal procedural complications.

Vacuum-Tech May Improve Outcomes of Kidney Stone Surgery

Vacuum-assisted flexible ureteroscopy may help clear large kidney stones as well as or better than mainstay treatments, with favorable outcomes after surgery.

Patient Requests That Can Put You In a Tough Position

Requests for emotional support animals, disabled parking placards, and, more recently, Medicaid work exemptions can prove challenging for physicians. Here’s what you need to know.

Europe’s Medical Loophole for Banned Doctors

A doctor struck off in France kept practicing in Belgium, exposing how gaps in EU medical oversight can let sanctioned clinicians cross borders.

Rare Adenoid Cystic Breast Cancer in a Woman

A woman with rare breast adenoid cystic carcinoma carries a BRIP1 variant of uncertain significance, highlighting the challenges in genetic risk assessment.

What the FDA's Hormone Therapy Decision Means for Aging Skin

Skin collagen content decreases at a rate of approximately 1%-2% per year in the early postmenopausal period, skin thickness diminishes, barrier function weakens, and moisture retention falters

US FDA Approves Pfizer's Bleeding Disorder Drug for Children

(Corrects paragraph 2 to say Hympavzi is the first non-factor therapy particularly for pediatric patients with hemophilia ⁠B, not all)

Ask the HF Expert: Advanced Therapies

Dr Yash Varma, a chief cardiology fellow, asks Dr Ileana Piña for her insights on when a patient with heart failure should be referred for advanced therapies.

Tile-Based Radiation to Treat Large Brain Metastases?

The GammaTile may improve outcomes over standard stereotactic RT after resection of large brain metastases, but a striking overall survival benefit in a phase 3 trial raises questions.

More Women With Breast Cancer Can Skip Axillary Dissection

The largest randomized trial of its kind to date found noninferior survival and better arm morbidity among patients with breast cancer who did not undergo completion axillary lymph node dissection.

Selpercatinib Cuts Recurrence Risk in Early RET+ NSCLC

In the first phase 3 trial of a RET inhibitor as adjuvant therapy, selpercatinib markedly improved event-free survival vs placebo in early-stage RET fusion-positive NSCLC.

Will PROTEUS Change the Playbook for Radical Prostatectomy?

New data now show that perioperative systemic therapy with apalutamide can improve outcomes after radical prostatectomy.

S1 Episode 4: Managing Heart Failure in ATTR-CM

From narrow volume windows to SGLT2 inhibitors and emerging devices, Drs Kevin Alexander and Sarah Cuddy discuss heart failure care in ATTR-CM.

Coconut Oil

Current evidence supports the use of this botanical agent to promote skin health, but more research is needed to ascertain more varied and curative applications for this popular natural product.

Micrometer CT Reveals Clitoral Neural Anatomy

High resolution 3-D imaging reveals a dense, branching dorsal nerve network in the clitoral glans, challenging anatomical assumptions and guiding surgical strategies to preserve sensation.

May 22 2026 This Week in Cardiology

Three more digoxin trials, yet another GLP-1 drug on the horizon, vagal nerve stimulation, trial inside baseball, and more on lipid guidelines are the topics John Mandrola, MD, discusses in this week’s podcast.

Recommended News For You

A hint regarding aspirin, the connection to colon cancer, the approval of the new Lutathera, artificial intelligence, and electronic records.

Housing aid linked to lower medical financial hardship among US renters with cancer

The Early Progression of Prostate Cancer Is Not Stopped by Metformin.

Breast Cancer Patients Living Longer Post-Medicaid Expansion

Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients

A small rise in cancer was observed following the 1986 Chernobyl accident.

Number of cancer survivors in the US reaches 18.6 million—projected to exceed 22 million by 2035

Recommended Articles For You

Exploring New Solutions for MCV Low: Unlocking the Potential for Improved Health 

Multi-Omic Rejuvenation of Aged Tissues With Transient Reprogramming and Its Therapeutic Potential 

Unlocking the Secret to Accurate ANC Calculation with This Informative Blog Post 

A New Hope: Exploring the Potential of Pegaspargase in Treating Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

More men with prostate cancer are avoiding unnecessary surgery

2.

Even when they are not paying attention, children are still learning.

3.

FDA Approves New Bladder Cancer First-Line Standard of Care.

4.

"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.

5.

AI is useful in low-resource areas for triaging breast masses.

1.

Community Cancer Awareness Through Survivor Advocacy Networks

2.

Evidence-Based Pathways for Survivorship Care Planning

3.

Red Blood Cell Aging and Clinical Implications

4.

Understanding Phyllodes Tumor: Symptoms, Diagnosis, and Treatment Options

5.

Clinical Trends in Oncology in Clinical Decision-Making

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part VI

2.

Efficient Management of First line ALK-rearranged NSCLC - Part V

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

4.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion

5.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot